Prediction: 2 Stocks That Will Be Worth More Than Rigetti Computing 1 Year From Now
Quantum computing stocks are having a moment.
Following Alphabet's revelation of its Willow quantum chip in December, quantum computing stocks including Rigetti Computing (NASDAQ: RGTI) soared, and attention has remained on the sector as Microsoft and Nvidia have made their own announcements about quantum computing.
Rigetti Computing is still a development-stage company, as it brought in just $10.8 million in revenue in 2024 and an operating loss of $68.5 million. Its revenue also declined by 10% during the year, a sign that investors' hopes for explosive growth are not showing up in the results so far.
Rigetti touted a new strategic collaboration with Quanta Computer, and it also made its first QPU (quantum processing unit) sale to an academic institution, selling one of its Novera QPU products to Montana State University.
At a market cap of $2.8 billion, Rigetti Computing is pricey for a stock with barely any revenue and negative revenue growth in recent quarters, setting it up for a potential pullback if the excitement around quantum computing fades.
With that risk in mind, here are two smaller stocks that look well-positioned to be worth more than Rigetti Computing a year from now.
Amplitude (NASDAQ: AMPL) is a cloud software stock that specializes in digital product analytics and optimization, meaning it gives companies the tools to see how customers are using their digital products so they can improve them and increase return on investment.
Amplitude's analytics software helped Peloton realize that social interaction was key to member retention. The technology also helped guide Burger King's "Whopper Detour" campaign, which offered customers a Whopper for $0.01 if they downloaded the app near a McDonald's.
The company went public near the tail end of the pandemic boom, and the stock plunged in 2022 like a lot of software stocks. However, management has said that post-pandemic-related churn is now behind it, and it expects its growth rate to improve over the coming years.
Amplitude is also focused on launching an artificial intelligence (AI) agent, which has the potential to be a game-changer for the company. It would accelerate customer insights and make it easier to find relevant information using a chat interface like ChatGPT.
At a market cap of $1.55 billion, Amplitude stock could top Rigetti in another year if Rigetti pulls back, or if Amplitude's AI agent gains significant traction.
Homebuilders have had a rough go of it in recent years as the housing market cooled after the pandemic ended, and it has remained soft as mortgage rates are still elevated.
However, there's a substantial opportunity for homebuilders like Dream Finders Homes (NYSE: DFH), as there is an estimated shortage of 4 million homes in the country.
Dream Finders Homes offers an appealing way to get exposure to the homebuilding sector, as it uses an asset-light business model pioneered by best-in-class homebuilder NVR. Rather than buying land outright, which can add a lot of balance sheet risk, Dream Finders Homes buys land options that it can exercise if it later chooses to build on that land.
The company primarily builds homes in the Southeast, and recent results have been promising.
In the fourth quarter, revenue jumped 35% to $1.5 billion, and business momentum looked even stronger with 46% net new orders to 1,611. The company also grew with the help of acquisitions, including the regional home builder Crescent Homes and the Jet HomeLoans mortgage loan originator, showing the company has multiple avenues for growth.
At a market cap of $2.27 billion, Dream Finders Homes could easily be worth more than Rigetti Computing in another year. If the macro climate improves and mortgage rates start to come down, Dream Finders Homes has the potential to surge, and its asset-light business model should protect the stock from a recession or broader economic weakness.
Before you buy stock in Dream Finders Homes, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Dream Finders Homes wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $697,245!*
Now, it's worth noting Stock Advisor's total average return is 845% — a market-crushing outperformance compared to 165% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of March 24, 2025
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Jeremy Bowman has positions in Nvidia. The Motley Fool has positions in and recommends Alphabet, Dream Finders Homes, Microsoft, NVR, Nvidia, and Peloton Interactive. The Motley Fool recommends Burger King parent Restaurant Brands International and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Prediction: 2 Stocks That Will Be Worth More Than Rigetti Computing 1 Year From Now was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
ReElement Technologies Corporation Receives $150 Million Letter of Interest from United States EXIM Bank to Advance the Nation's Largest Critical Mineral Refinery
Marion Advanced Technology Center positioned to become the largest multi-mineral, multi-feedstock rare earth and critical mineral refinery in the United States EXIM's support of the proposed capital funding plan for the Marion Advanced Technology Center advances the "Make More In America" initiative amid rising competition from China in critical mineral supply chains FISHERS, IN / / June 9, 2025 / American Resources Corporation (NASDAQ:AREC) ("American Resources"), through its holding in ReElement Technologies Corporation ("ReElement" or "RTC"), a leading U.S. innovator in rare earth element (REE) and critical mineral refining, announced today that it has received support for the proposed capital funding plan by ReElement Technologies Corporation for the Marion Advanced Technology through a Letter of Interest (LOI) from the Export-Import Bank of the United States (EXIM) for up to $150 million in financing. This financing will support the expansion of ReElement's state-of the-art rare earth, critical mineral and defense mineral refining project that is set to become the nation's largest multi-mineral, multi-feedstock rare earth and critical mineral refinery. The Marion facility builds on ReElement's successful commercial operations in its Noblesville, Indiana facility supplying highly refined critical mineral products to both the commercial and defense markets. ReElement's Advanced Separation Platform Aligned with National Mandate for Mineral Independence ReElement Technologies' rare earth element (REE) separation process - based on its patented and proprietary chromatography-based refining methods - represents a transformative leap forward in strengthening the U.S. industrial base for critical minerals. This innovative platform directly supports Presidential Executive Orders focused on restoring mineral independence and securing national supply chains. ReElement's process consistently produces ultra-high-purity (99.5%+) rare earth oxides and compounds such as neodymium, dysprosium, terbium, gallium, antimony, samarium, yttrium, gadolinium, and others - key materials required for metallization, magnet production, and advanced technologies across defense and commercial applications. Mark Jensen, CEO of ReElement Technologies commented, "We're honored to receive positive support from the Export-Import Bank of the United States. Our team has worked tirelessly to validate our next-generation refining platform and strategically scale production to meet the growing needs of both commercial and defense sectors. From day one, our vision has been clear: the U.S. must regain control of the midstream segment of the critical mineral supply chain if we are to compete globally. Support from the federal government significantly accelerates the buildout of additional refining capacity at our 42-acre Marion campus and beyond. We are laser-focused on scaling up production of refined rare earth oxides and defense-grade mineral compounds that are urgently needed here at home. As we see it, ReElement is among the only - if not the only - commercial entity in the United States capable of producing these materials at quantities and cost structures that rival or even undercut the Chinese industrial base. We're excited to expand our footprint domestically and internationally, delivering long-term supply chain resilience and a diversified source of critical and rare earth elements." Federal Support Aligned with New Executive Action on U.S. Mineral Production The issuance of this Letter of Interest aligns with the March 20, 2025, Executive Order titled "Immediate Measures to Increase American Mineral Production". The order directs federal agencies, including EXIM, to streamline permitting, unlock financing, and establish offtake agreements for U.S.-based critical mineral processing facilities. It also sets near-term mandates for fast-tracking approvals, mobilizing capital, and stockpiling strategic materials vital to national defense, clean energy, and next-generation technology infrastructure. ReElement's Technological Edge: Chromatographic Separation and Purification ReElement employs continuous chromatography, a breakthrough in rare earth separation and purification that delivers: Aqueous Chemistry - Eliminates the need for toxic and hazardous organic solvents, making the process safer and more environmentally friendly. Lower Capital Expenditures - A few chromatography units can replace hundreds or even thousands of mixer-settlers to achieve the same throughput and product requirements. High Versatility - An intrinsic-parameter-based design and predictive simulation tools allow for rapid, adaptable refining across various feedstocks and production scales. Modular and Scalable Capacity - Easily expands processing volumes in alignment with growing feedstock availability. Localized Processing - Reduces the need for raw ore transportation across the globe, strengthening supply chain security and efficiency. ReElement's refining platform - originally developed by Purdue University for pharmaceutical purification - has been reengineered to separate rare earths and critical minerals with exceptional efficiency, scalability, and purity. Their patented, programmable platform handles multiple feedstocks and minerals, enabling rapid modular deployment across locations and resource types. Unlike legacy solvent extraction methods, it uses far fewer chemicals, requires less space, and generates minimal waste - making it faster to permit and simpler to co-locate near feedstock or end-use customers. This breakthrough eliminates a major chokepoint in global critical mineral supply chains, which has been dominated by single-source processing, no longer tenable as the U.S. must forge critical mineral supply chain independence, both through refining in the U.S. and in partnership with allies abroad. About ReElement Technologies Corporation ReElement Technologies Corporation is a leading provider of high-performance refining capacity for rare earth and critical battery elements. Its multi-mineral, multi-feedstock platform technology focuses on the refining of recycled material from rare earth permanent magnets and lithium-ion batteries, concentrated ores and brines, as well as coal-based waste streams and byproducts to create a cost effective and environmentally-safe, circular supply chain. ReElement has developed its innovative and scalable "Powered by ReElement" process which collaboratively utilizes its exclusively licensed intellectual property within its partners' material processing flow sheets to more efficiently support the global supply chain's growing demand for magnet and battery-grade products. For more information visit or connect with the Company on Facebook, Twitter, and LinkedIn. About American Resources Corporation (NASDAQ:AREC) American Resources Corporation is a leader in the critical mineral supply chain, developing innovative solutions both upstream and downstream of the refining process. The company and its affiliates focus on the extraction and processing of metallurgical carbon and iron ore, essential ingredients in steelmaking, as well as critical and rare earth minerals for the electrification market and recycled metals. Leveraging its affiliation and former parent status of ReElement Technologies Corporation, a leading provider of high-performance refining capacity for rare earth and critical battery elements, American Resources is investing in and developing efficient upstream and downstream critical mineral operations. These operations include mining interests in conventional and unconventional sources, recycling, and manufacturing. American Resources has established a nimble, low-cost business model centered on growth, which provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets while also continuing to acquire operations and significantly reduce their legacy industry risks. Its streamlined and efficient operations are able to maximize margins while reducing costs. For more information visit or connect with the Company on Facebook, Twitter, and LinkedIn. Special Note Regarding Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes", "may", "will", "should", "would", "could", "continue", "seeks", "anticipates", "plans", "expects", "intends", "estimates", or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved. Investor Contact:JTC Team, LLCJenene Thomas(908) 824 - 0775arec@ Media Inquiries:Marjorie Weisskohl703-587-1532mweisskohl@ Company Contact:Mark LaVerghetta317-855-9926 ext. 0investor@ SOURCE: American Resources Corporation View the original press release on ACCESS Newswire
Yahoo
23 minutes ago
- Yahoo
Webull Appoints Walter Bishop to Board of Directors
Mr. Bishop to serve as Independent Director and member of the Audit, Compensation and Nominating and Corporate Governance Committees ST. PETERSBURG, Fla., June 9, 2025 /PRNewswire/ -- Webull Corporation (NASDAQ: BULL) ("Webull" or the "Company"), the owner of the Webull online investment platform, today announced the appointment of Walter Bishop as independent director to its Board of Directors, effective June 8, 2025. Mr. Bishop will serve as a member of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Mr. Bishop brings extensive experience in the finance industry, having held senior leadership roles at Nordbanken U.S., Barclays and Deutsche Bank. From 1997-2019, Mr. Bishop held several leadership roles at Deutsche Bank (NYSE: DB), including as the U.S. Chief Operating Officer and Chairman of the Board and Audit Committee for DB Trust Company Delaware. Before joining Deutsche Bank, he served as the Chief Administrative Officer for Barclays Bank U.S., Deputy General Manager and Chief Financial Officer for Nordbanken U.S., and as an audit manager for KPMG Peat Marwick. Throughout his career, he has been instrumental in the development, oversight and execution of complex financial strategies. His deep knowledge of financial markets and corporate governance will further strengthen the Board of Directors. "We are pleased to welcome Wally to Webull's Board of Directors," said Anquan Wang, Chairman of the Board of Directors. "Wally's appointment reflects our ongoing commitment to enhancing the independence and expertise of our board. We are confident that he will bring valuable insight and perspective, and we look forward to working with him as Webull continues to execute on its strategic growth pillars." In particular, Mr. Bishop is an industry-leading expert in regulatory compliance, independent financial audits, and corporate governance. He currently serves as the lead independent director and audit committee chairman of Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a custom optics and photonics manufacturer. He joined Syntec in November 2023 following its merger with OmniLit Acquisition Corp., where he had served as a director since April 2023. From April 2019 to December 2024, Mr. Bishop served as a director and audit committee chairman of Highline Management Inc., an alternative asset management company. In 2021, he acted as a senior advisor to Thunder Bridge Capital Acquisition II, which merged with Indie Semiconductor (NASDAQ: INDI). Mr. Bishop holds a Master of Business Administration from St. John's University and a bachelor's in public accounting from Baruch College (CUNY). This appointment expands the Board of Directors to six members, two of whom are independent. The Company believes this strengthened governance structure will support its mission of delivering long-term value to shareholders. About Webull Webull Corporation (NASDAQ: BULL) owns and operates Webull, a leading digital investment platform built on next-generation global infrastructure. Through its global network of licensed brokerages, Webull offers investment services in 14 markets across North America, Asia Pacific, Europe, and Latin America. Webull serves more than 24 million registered users globally, providing retail investors with 24/7 access to global financial markets. Users can put investment strategies to work by trading global stocks, ETFs, options, futures, and fractional shares through Webull's trading platform, which seamlessly integrates market data and information, its user community, and investor education resources. Learn more at You may also access certain information on Webull and its securities on the website of the SEC at where Webull will, among others, be filing reports, such as Reports on Form 6-K and its Annual Report on Form 20-F. Cautionary Note Regarding Forward-Looking Statements This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this press release or other statements of the Company are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including "anticipate," "expect," "suggests," "plan," "believe," "predict," "potential," "seek," "future," "propose," "continue," "intend," "estimates," "targets," "projects," "should," "could," "would," "may," "will," "forecast" or the negatives of these terms or variations of them or similar terminology although not all forward-looking statements contain such terminology. All forward-looking statements are based upon current estimates and forecasts and reflect the reasonable views, assumptions, expectations, and opinions of the Company and its management as of the date of this press release, and are therefore subject to a number of factors, risks and uncertainties, some of which are not currently known to the Company and its management and could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to: (1) the ability of the Company to capitalize on the anticipated benefits of the business combination, to grow and manage growth profitably, maintain relationships and deepen engagement with users, customers and suppliers, and retain its management and key employees; (2) the reliance of key functions of the Company's business on third-parties and the risk that the Company's platform and systems rely on software and applications that are highly technical and may contain undetected errors that could result in unexpected network interruptions, failures, security breaches, or computer virus attacks; (3) the risks associated with the Company's global operations and continued global expansion, including, but not limited to, the risks related to complex or constantly evolving political or regulatory environments that may result in substantial costs or require adverse changes to the Company's business practices; (4) the Company's estimates of expenses and costs (including costs related to the business combination), of profitability or of other operational and financial metrics as well as the Company's expectations regarding demand for and market acceptance of its products and service; (5) the Company's reliance on trading related income, including payment for order flow ("PFOF"), and the risk of new regulation or bans on PFOF and similar practices; (6) the Company's exposure to fluctuations in interest rates, rapidly changing interest rate environments, volatile prices of securities and trading volumes; (7) the Company's reliance on a limited number of market makers and liquidity providers to generate a large portion of its revenues, and the negative impact of the loss of any of those market makers or liquidity providers; (8) the effects of competition in the Company's industry and the Company's need to constantly innovate and invest in new markets, products, technologies or services to retain, attract and deepen engagement with users; (9) changes in international trade policies and trade disputes that could result in tariffs, taxes or other protectionist measures adversely affecting our business; (10) risks related to general political, economic and business conditions globally and in jurisdictions where the Company operates; (11) risk of further actions taken by various government bodies in the United States that have made the Company the subject of inquiries and investigations relating to concerns about our connections to China; (12) the risk that the failure to protect customer data and privacy or to prevent security breaches relating to the Company's platform could result in economic loss, damage to its reputation, deter customers from using its products and services, and expose it to legal penalties and liability; (13) risks related to the Company's need as a regulated financial services company to develop and maintain effective compliance and risk management infrastructures as well as to maintain capital levels required by regulators and self-regulatory organizations; (14) the ability to meet, or continue to meet, stock exchange listing standards; (15) the possibility of adverse developments in pending or new litigation and regulatory investigations; (16) risks related to the Company's securities and its status as a foreign private issuer and the fact that the information the Company is required to file with or furnish to the SEC may be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers; (17) the effectiveness of the Registration Statement for resales or exercises of our warrants throughout the 30-day Redemption Period (as defined in the Warrant Agreement) as well as the risks related to the offer and resale of our securities, such as dilution from the issuance of additional Class A Ordinary Shares upon the exercise of warrants, and increased volatility, or significant declines, in the price of our securities based on increased trading activity and the perception that sales of our securities may occur; and (18) other risks and uncertainties that are more fully described in filings made, or to be made, by the Company with the SEC, including in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's filings with the SEC. The foregoing list of factors is not exhaustive. Reported results should not be considered an indication of future performance. There may be additional risks that the Company and its management presently do not know about or that the Company and its management currently believe are immaterial that could also cause actual results to differ materially from those contained in the forward-looking statements. In light of these factors, risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur, and any estimates, assumptions, expectations, forecasts, views or opinions set forth in this press release should be regarded as preliminary and for illustrative purposes only and accordingly, undue reliance should not be placed upon the forward-looking statements. The Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Webull Investor Relationsir@ Webull Media Relations5W Public RelationsNicholas KoulermosWebull@ 999-5585 View original content to download multimedia: SOURCE Webull Corporation Sign in to access your portfolio
Business Wire
31 minutes ago
- Business Wire
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND ® in Rare Blood Disorders
AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. ('Avanzanite'), a fast-growing commercial-stage specialty pharmaceutical company dedicated to bringing rare disease medicines to patients across Europe, announced today an exclusive agreement with Agios Pharmaceuticals Inc. (Nasdaq: AGIO), a Boston-based biotech company focused on the development and commercialization of rare disease medicines. Under the agreement, Avanzanite will commercialize and distribute PYRUKYND® (mitapivat) across the European Economic Area, the UK and Switzerland. 'This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe' Share 'This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe,' said Adam Plich, Founder and CEO of Avanzanite. 'We provide biotech partners with a capital-efficient path to sustainable patient access – without the burden of building a costly local infrastructure. We look forward to working with Agios to help bring PYRUKYND® to patients across Europe, further advancing our efforts to set a new benchmark for biotech commercial and distribution partnerships in the region. This is just the beginning.' PYRUKYND®, a first-in-class, oral, pyruvate kinase (PK) activator, is approved by the European Commission and the UK's Medicines and Healthcare products Regulatory Agency for the treatment of adult patients with PK deficiency. PK deficiency is an ultra-rare, inherited condition that causes premature red blood cell breakdown, leading to chronic anemia, serious complications, and reduced quality of life. Until recently, there were no approved treatments. Agios also has a robust mid- and late-stage pipeline, with clinical programs focused on other rare diseases, including thalassemia and sickle cell disease. The partnership also includes potential future indications. Avanzanite is rapidly scaling its operations, having tripled its revenue in Q1 2025 year-over-year, with two rare disease medicines already on the market. Over the next 12 months, the company will expand into 32 European countries, including new territories of Italy, France, the UK, Romania, and Spain. 'Avanzanite goes truly pan-European,' concluded Plich. 'And as we expand across the continent, our promise stays the same – making sure no patient is left behind.' About Avanzanite Avanzanite is redefining launches of rare disease medicines across Europe. Founded in 2022 and based in Amsterdam, the company partners with biotech innovators to unlock the full commercial value of orphan medicines continent-wide. With our deep expertise in market access, we navigate Europe's complex landscape like master chess players – ensuring no patient is left behind. Learn more at
